Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-065794
Filing Date
2015-11-16
Accepted
2015-11-16 14:03:46
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v423500_10q.htm 10-Q 286665
2 EXHIBIT 31.1 v423500_ex31-1.htm EX-31.1 9973
3 EXHIBIT 32.1 v423500_ex32-1.htm EX-32.1 4635
  Complete submission text file 0001144204-15-065794.txt   2706383

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20150930.xml EX-101.INS 613519
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20150930.xsd EX-101.SCH 29032
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20150930_cal.xml EX-101.CAL 23852
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20150930_def.xml EX-101.DEF 161998
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20150930_lab.xml EX-101.LAB 212315
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20150930_pre.xml EX-101.PRE 188680
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 151233360
SIC: 2836 Biological Products, (No Diagnostic Substances)